GSK/Sanofi vaccination medication code
Codelist metadata
-
Coding system
- Dictionary of Medicines and Devices
-
Coding system release
- unknown
-
Organisation
- PRIMIS Covid Vaccination Uptake Reporting
-
Codelist ID
- primis-covid19-vacc-uptake/sadrx
-
Version Tag
- v1.5.3
-
Version ID
- 354d9d6e
Versions
About
Description
Taken from the SAD1/2RX_COD fields in SARS-CoV2 COVID19 Vaccination Uptake Reporting Codes 20_21, published by PRIMIS.
© PRIMIS - the University of Nottingham 2021
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| code | term |
|---|---|
| 40506311000001105 | COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent D614 [recombinant]) 5micrograms/0.5ml dose suspension for injection multidose vials (Sanofi Pasteur) |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.